H. Koller (Vienna, Austria), G. Kovacs (Graz, Austria)
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results M. Suzuki, H. Makita, S. Konno, K. Shimizu, N. Taniguchi, Y. M. Ito, M. Nishimura (Sapporo, Japan)
| |
Is controlled oxygen therapy in COPD patients presenting in acute respiratory failure sub-optimal prior to commencement of NIV? S. Karmali, T. Win (Stevenage, United Kingdom)
| |
Impact of diabetes in patients admitted with acute exacerbation of COPD R. Benson, N. Kazmi, A. Pocock, S. Huq, S. Agarwal (Prescot, United Kingdom)
| |
The prognostic value of elevated levels of troponin I (Tn I) and heart-type fatty acid binding protein (H-FABP) in hospitalized COPD patients with acute respiratory failure (ARF) G. Baimakanova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease Y. Wang, F. Wen (Chengdu, China)
| |
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease R. Marcun, A. Sustic, P. Mesko Brguljan, S. Kadivec, M. Kosnik, J. Farkas, M. Lainscak (Golnik, Ljubljana, Slovenia; Rijeka, Croatia)
| |
Predicting hospital readmission in patients discharged following acute exacerbations of COPD (AECOPD) J. Steer, J. Gibson, S. Bourke (North Shields, Newcastle-upon-Tyne, United Kingdom)
| |
Association of post-traumatic stress disorder and number of exacerbations in COPD patients P. Teixeira, L. Porto, C. Kristensen, A. Santos, P. Lima, S. Menna Barreto (Porto Alegre, Brazil)
| |
Impact of patient nutritional status on acute exacerbation of COPD F. Chermiti Ben Abdallah, I. Sahnoun, W. Bouhawel, A. Chtourou, S. Taktak, R. Mahouachi, A. Ben Kheder (Ariana, Tunisia)
| |
Can acute phase proteins predict survival in ventilated patients with acute exacerbation of COPD? G. Agmy, H. Maghlouf, S. Wafy, Y. Ahmed, S. Radwan (Assiut, Egypt)
| |
A comparison of specific health- related quality of life questionnaires to predict COPD exacerbations A. Consuegra, M. Blanco-Aparicio, I. Vazquez, H. Verea-Hernando (Coruna, Spain)
| |
30-days mortality in patients admitted with COPD J. Kjaergaard, L. Braagaard, J. T. Wilcke, J. B. Jørgensen, P. Tønnesen (Hellerup, Copenhagen, Denmark)
| |
Influence of COPD exacerbations on health related quality of life A. David, A. Corlateanu (Chisinau, Republic Of Moldova)
| |
Nutritional status of COPD patients with complete respiratory failure on long term home oxygen therapy D. Posluszna, E. Swietlik, A. Doboszynska, K. Kuczynska, K. Rzeszutek, L. Dymek, A. Dymek (Warsaw, , Lodz, Zawadzkie, Poland)
| |
Reducing hospital admission in COPD exacerbation by urgent oxygen provision and home monitoring of capillary blood gases H. Clague, M. Herring, P. Frear (Sunderland, Hebburn, United Kingdom)
| |
Comparison of different dosage nebulised budesonide in COPD exacerbation E. Yilmazel Ucar, O. Araz, D. Ozturk, M. Akgun, L. Saglam, M. Gorguner (Erzurum, Turkey)
| |
COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level T. Pertseva, K. Gashynova, O. Bratus, N. Petrik (Dnipropetrovs, Ukraine)
| |
Relation between metabolic syndrome and acute exacerbation of COPD H. Ben Abdelghaffar, E. Tangour, S. Fenniche, L. El Fekih, D. Greb, I. Akrout, H. Hassene, W. Ben hamad, H. Kammoun, D. Belhabib, M.L. Megdiche (Ariana, Tunisia)
| |